Skip to main content
Veterinary Medicines

Benestermycin vet. Intramammär salva

Authorised
  • Benethamine penicillin
  • Framycetin sulfate
  • Penethamate hydriodide

Product identification

Medicine name:
Benestermycin vet. Intramammär salva
Active substance:
  • Benethamine penicillin
  • Framycetin sulfate
  • Penethamate hydriodide
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benethamine penicillin
    56.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Framycetin sulfate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Penethamate hydriodide
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Milk
        37
        day
      • Meat and offal
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC25
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
  • Lohmann Pharma Herstellung GmbH
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 8804
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 20/04/2023

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."